04/07/2021
About the SARS-2 COVID-19 Virus
COVID-19, MERS & SARS
01/04/2021
Mobile Research Networks for Long-haulers
COV-19 Research Library
01/04/2021
The COVID-19 Long-haul Community
The Foundation interfaces with its membership through the use of a mobile social research network. It uses Forums, Groups, Chats, Blogs and COV-19 Surveillance Applications and smart telemetry to maintain communities of those recovering from Long-haul illnesses. We securely collect and manage HIPAA compliant CDISC standardized data and use it to conduct epidemiologic, genomic and clinical research to gain a complete understanding of COV-19 and its long-term effects.
01/02/2021
COVID Foundation Research Networks
The Foundation manages a mobile research network that is specifically designed to provides clinicians and scientists with all of the tools necessary for the research of COVID-19 and the management of research and grant administration. Our Research Toolkit Includes:
01/04/2021
Research & Grant Submission
The Foundation partners with academic researchers, clinicians and epidemiologists and funds research studies of its own design as well as those submitted and approved through its electronic grant submission platform. In cases where we are pursuiing our own scientific investigation, the Foundation issues Requests for Proposal based on our own protocol study design. We also accept unsolicitied research projects that drug and diagnostic companies and CRO's wish to pursue in partnership with our COVID-19 subject registries and study enrollment clinical data bases.
11/29/2021
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
Authors: Ger T. Rijkers,1,2,*Nynke Weterings,1Andres Obregon-Henao,3Michaëla Lepolder,1Taru S. Dutt,3Frans J. van Overveld,1 and Marcela Henao-Tamayo3AbstractInfection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes Coronavirus Disease 2019 (COVID-19), which has reached pand
11/29/2021
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
Authors: Yuyang Lei,1,2,*Jiao Zhang,1,2,5,*Cara R. Schiavon,8,9Ming He,5Lili Chen,2Hui Shen,5,10Yichi Zhang,5Qian Yin,2Yoshitake Cho,5Leonardo Andrade,8Gerald S. Shadel,9Mark Hepokoski,6Ting Lei,3Hongliang Wang,4Jin Zhang,7Jason X.-J. Yuan,6Atul Malhotra,6Uri Manor,8,†Shengpeng Wang,2,†Zu-Yi Yuan,1,
11/29/2021
THE NOVEL CORONAVIRUS’ SPIKE PROTEIN PLAYS ADDITIONAL KEY ROLE IN ILLNESS
Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular diseaseLA JOLLA—Scientists have known for a while that SARS-CoV-2’s distinctive “spike” proteins help the virus infect its host by latching on to healthy cells. Now, a major new study s
01/04/2021
Granular Longitudinal Telemetered COVID-19 Histories
01/04/2021
Our Long-haul Data Capture Methodology
04/09/2021
The Foundation Manages a Global Clinical Research Network
All Foundation research studies and grants management are integrated into a single platform. Clinicians become part of our Professional Long-haul network and are afforded the ability to participate with one another as valued members of our Social Network Community.
01/04/2021
Clinical Reports & Analytics
The Foundation's Social Research Network is constantly capturing a wide-variety of data about COVID-19 from our Long-haul volunteers. Detailed medical and social histories and clinical care and outcome data as well as activities of daily living and measures of disability are stored in HIPAA compliant and encrypted databases. Data is entered via mobile device, telemetry or computer keyboard and is CDISC and SDTM standardized for electronic submission.
04/11/2021
Grant Writing & Submission
Our clinical research teams are afforded access to deidentified clinical data assembled from our Long-haul volunteers for the design of study protocols and the selection of clinical end-points. From there, they are provided with all of the tools necessary to submit proposals and if chosen manage every step of each experiment through study lock and publication.
04/09/2021
Grants Management
05/26/2021
Volunteer to Fight COVID-19 Long-haul Disease
VOLUNTEER
01/04/2021
The COV19 Long-hauler Foundation, Who Are We?
The COVID19 Long-hauler Research Foundation is a 501 (c)(3) tax-exempt non-profit corporation that is dedicated to helping people recover from the SARS-2 Covid Virus. The Foundation maintains a wide variety of educational, scientific and medical resources to support those long-haul patients who have experienced lasting side-effects. It maintains registries, a robust CDISC & SDTM standardized COVID19 clinical data warehouse and A.I. assisted medical monitoring system for disease, drug and diagnostic research. It also operates specialized Social Networks that link long-haulers together for collaborative COVID19 community support through forums, groups, chats and blogs.
04/21/2021
Please Donate & Volunteer"
DONATE HERE

Search

07/03/2021
Managing COVID-19 Long-haul Illnesses
Currently, the medical and public health communities don't have a good handle on COVID-19, let alone how to define its long-term, chronic phase. "We don't have a huge body of evidence at this point," says Mehta, a researcher at John's Hopkins. Outside of a few small studies from the United Kingdom, most evidence of Long COVID has been reported anecdotally through grassroots efforts like the Body Politic COVID-19 Support Group, Survivor Corps, Patient-Led Research for COVID-19, and Long Haul COVID Fighters. Until recently, there hasn't been many resources devoted to long-haulers. Now, a year into the pandemic, as more individuals continue to struggle with the long-term effects of the disease, the focus is shifting. More research is forthcoming, including a new initiative from the National Institutes of Health and studies at institutions including Johns Hopkins and Mount Sinai focused on their clinic patients.
07/02/2021
About The Long-haul Foundation
The COVID19 Long-hauler Research Foundation is a 501 (c)(3) tax-exempt non-profit corporation that is dedicated to helping people recover from the SARS-2 COVID-19 Virus. Governments and the press have focused almost all of their attention on the COVID-19 pandemic and the acute stage of this illness and mortality statistics. However, very little attention has been paid to the very large number of survivors of SARS-2 and the lasting long-term effects that they suffer from.
07/02/2021
About SARS-2 COVID-19 Long-haul Disease
According to a study published in the Annals of Clinical and Translational Neurology, even after the acute COVID-19 infection cleared, an overwhelming number of people who contracted the SARS-2 COVID-19 virus report a string of neurological problems including brain fog, fatigue, dizziness, headaches, and numbness and tingling. Another study from the University of Washington that was published in February found that 32.7% of COVID-19 outpatients and 31.3% of hospitalized patients developed long-haul symptoms that included hemorrhages, blood clots, cardiac myopathies, digestive disorders, sleep disturbance, loss of taste and smell, among others. Currently there are over 100 reported Long-haul illnesses.
07/02/2021
Please Donate
DONATE Using PayPal
05/04/2021
DONATE TO CURE LONG-HAUL ILLNESSES
Donate Using PayPal